Test your knowledge of the week’s events as reported in The Wall Street Journal.

Thank you, John, and good afternoon, everyone. It is my pleasure to welcome you to Waystars' Investor conference call. Matt Hawkins, Waystar's Chief Executive Officer; and Steven Oreskovich, Waystar's ...

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including Sanofi's $1.6B acquisition ...

The acquisition led by Advent International will see the two AI-powered companies combine forces to improve the healthcare ...

Spain is increasingly seen as an attractive market for international private equity, Francisco Cerezo, partner at law firm DLA Piper, told PE Hub. “The Spanish M&A and private equity markets have ...

This stock is worth watching for several compelling reasons, including a gamechanging acquisition, ahead of its upcoming earnings.

Waystar Holding Corp. shows revenue growth and strategic expansion with the Iodine acquisition. Click for why high valuations and muted growth may temper WAY's appeal.

Louisville's newest public company raises nearly $1 billion © 2025 American City Business Journals. All rights reserved. Use ...

Waystar to acquire Iodine Software for $1.25 billion to enhance AI tools; deal expected to be accretive to growth and margins by 2027.

Waystar has agreed to acquire Iodine Software, an Austin-based provider of AI-powered clinical intelligence, for $1.25 billion. The sellers include majority shareholder Advent International and Iodine ...

Waystar has signed a definitive agreement to acquire AI-powered revenue cycle management company Iodine Software. The proposed $1.25 billion deal will be funded with a 50/50 mix of cash and stock ...

The acquisition will enable Waystar to automate tasks such as utilisation management and clinical documentation integrity.